top of page

Evidence of health treatments efficacy

Telix implementation guide

Evidence of Health Treatment Efficacy Implementation Guide published by Linca Telecomunicações Ltda. This guide is not an authorized publication; it is the continuous build for version 1.0.0. This version is based on the current content of <link> and changes regularly. See the implementation guide for version fhir r6

1 Extension

IG Standards status: draft updated on 2026-04-10

Version: 1.0.0-draft

Computable Name: Telix IG

The artifact being compared to the referenced artifact.

1.1 Context of Use

This extension is used on Evidence.extension to represent the country where the clinical study was conducted.

1.2 Usage info
Usage:

Use this extension when an Evidence resource needs to identify the country where the clinical study was conducted.

  • Use this Extension: Evidence.extension

  • Examples for this Extension: Evidence/example-study-country

The value should be represented as a CodeableConcept using a standardized country code, such as US for United States.

1.2 Formal Views of Extension Content
Description Differentials, Snapshots, and other representations.
Design sem nome (11).png

valueCodeableConcept

1..1

UsageContext

Concept - reference to a terminology

Design sem nome (11).png

coding

1..1

Coding

Country being specified in the article

Design sem nome (11).png

system

1..1

uri

Identity of the country: https://hl7.org/fhir/valueset-country.html

Design sem nome (11).png

code

1..1

code

Code used to identify the country by the ISO code

Design sem nome (11).png

display

1..1

string

Name of the country where the study described in the article was conducted

network.png

extension:studyCountry

1..1

string

Country where the study described in the article was conducted. 

https://treatments.telix.health/implementationguide/extensions/study-country

Telix Implementation Guide - 2026 - Linca Telecomunicações

bottom of page